Clinical Trial Update: Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) Cancer [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 neoadjuvant study comparing SLOT versus SOX regimens in locally advanced, resectable gastric and gastroesophageal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophagogastric Junction Cancer
• Gastric Cancer

Drugs mentioned

• SLOT regimen
• SOX regimen (S-1 and oxaliplatin)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Gastric Adenocarcinoma | Phase 3 | Status: UNKNOWN